Onceweekly Trulicity is a type 2 diabetes medication that helps your body release its own insulin and can help improve your A1C and blood sugar numbers. For people living with T2DM, Trulicity lowers the risk of CV events like heart attack, stroke and CV death in people with known heart disease or multiple risk factors.
| Website | http://www.trulicity.com |
| Revenue | $4 million |
| Employees | View employees |
| Industry | Manufacturing General, Manufacturing |
| Competitors | Merck & Co., Inc., Sanofi, AstraZeneca, Regeneron, Lantus, Jardiance, INSULUX Metal Industries LLC, Afrezza, Mounjaro® (tirzepatide) HCP +18 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular Trulicity employee's phone or email?
The Trulicity annual revenue was $4 million in 2026.
The NAICS codes for Trulicity are [32541, 325, 3254, 32].
The SIC codes for Trulicity are [283, 28].